[Skip to Navigation]
May 1994

Prepublication Blackout in the Optic Neuritis Treatment Trial-Reply

Author Affiliations

Tampa, Fla

Arch Ophthalmol. 1994;112(5):582. doi:10.1001/archopht.1994.01090170025011

In reply  We appreciate having the opportunity to respond to the thoughtful comments of Drs Slavin and Burde. As will be evident from our discussion below, dissemination of our results in a timely and appropriate manner was given considerable deliberation by the study investigators as well as the National Eye Institute (NEI), which funded the ONTT.A preliminary analysis of the data showing a potential beneficial treatment effect was reviewed by the study's executive committee in November 1992. The committee recognized that, if true, the findings were very important. However, they recognized that the interpretation was complicated because, although the assessment of MS was a preplanned objective of the study, the study design was primarily developed to assess visual recovery.Over the next several months, measures were taken to evaluate potential sources of bias, confounding, and data errors as possible explanations for the apparent treatment effect, including (1) the review

Add or change institution